3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial

BACKGROUND: Posttraumatic stress disorder often does not resolve after conventional psychotherapies or pharmacotherapies. Pilot studies have reported that 3,4-methylenedioxymethamphetamine (MDMA) combined with psychotherapy reduces posttraumatic stress disorder symptoms. AIMS: This pilot dose respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Ot’alora G, Marcela, Grigsby, Jim, Poulter, Bruce, Van Derveer, Joseph W, Giron, Sara Gael, Jerome, Lisa, Feduccia, Allison A, Hamilton, Scott, Yazar-Klosinski, Berra, Emerson, Amy, Mithoefer, Michael C, Doblin, Rick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247454/
https://www.ncbi.nlm.nih.gov/pubmed/30371148
http://dx.doi.org/10.1177/0269881118806297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247454/
https://www.ncbi.nlm.nih.gov/pubmed/30371148
http://dx.doi.org/10.1177/0269881118806297

Ejemplares similares